Ischemic heart disease, Vitamin D deficiency.
Conditions
Interventions
Intervention 1: Intervention group: getting oral vitamin D 50000 IU pearl weekly up to 2 months, zahravi pharmaceutical company. Intervention 2: Control group: getting oral Vitamin D placebo pearl wi
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: Vitamin D level less than 30 ng/ml Ischemic heart disease : stable angina , acute coronary syndrome Age from 40 to 65 years
Exclusion criteria
Exclusion criteria: Coronary artery bypass grafting (CABG) indications Any life threatening disease Any vitamin supplementation use Severe vitamin D deficiency ( < 10 ng / ml )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), triglyceride, total cholesterol. Timepoint: before intervention and after 2 months (end of the study). Method of measurement: laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Sadeghi
Esfahan University of Medical Sciences
Outcome results
None listed